INTRODUCTION
Vascular damage and inflammatory processes allow for platelet adhesion and the exposure of tissue factor to blood triggering the blood coagulation response. The resulting series of proteolytic activation steps on the surface of activated cells culminates in thrombin formation and the conversion of soluble fibrinogen to insoluble fibrin. 1 Binding of clotting factors to membranes facilitates assembly of the intrinsic Xase and prothrombinase enzyme complexes and profoundly increases the rate of cleavage of their cognate biological substrates thereby localizing enhanced product formation to the site of vascular damage. 2 To mitigate unwanted clot formation, assembly of the intrinsic Xase and prothrombinase complexes requires cell activation and exposure of phosphatidylserine on the outer leaflet of the cell membrane. [3] [4] [5] Although activated platelets, microparticles, leukocytes, endothelial, and even red cells support their assembly and function to varying degrees, it is the activated platelet surface that is, by far, considered the preeminent site for the function of these enzyme complexes. [4] [5] [6] [7] [8] [9] [10] This paradigm is largely based on extrapolations from in vitro studies with isolated platelets in the absence of key participants that could further contribute to clot formation within the vasculature. A weakness in this extrapolation lies in predicting the contribution of different cells to function on the basis of measurements performed using "optimal" agonist concentrations to stimulate various cell types with little knowledge of the agonist concentrations encountered in flowing blood following vascular damage. Consequently, it remains uncertain how other activated cells, in addition to platelets, contribute to thrombin generation in vivo following different types of vascular injury.
Mouse models and advances in intravital video microscopy to visualize the dynamics of thrombus formation in vivo provide new opportunities to test hypotheses within the context of the authentic injured vasculature. [11] [12] [13] Work employing laser-induced injury to the mouse For personal use only. on April 12, 2017 . by guest www.bloodjournal.org From cremasteric arteriole has revealed surprising findings that challenge otherwise accepted ideas about thrombus formation. The findings point to a significant role for other activated cells in addition to platelets, in supporting fibrin formation. This is revealed by significant amounts of fibrin deposition following laser injury despite large reductions in adherent platelets using a pharmacologic approach or mice deficient in protease activated receptor (PAR) 4. [14] [15] [16] While this could be related to the type of injury or other factors, these findings warrant a more detailed evaluation of the cellular site(s) of coagulation enzyme complex formation in vivo.
Here, we generated site-specifically labeled fluorescent species of coagulation FVa and FXa with well-established properties to advance our understanding of coagulation enzyme function and the relative contribution of blood cells and the vasculature to the regulation of clot formation in vivo.
Surprisingly, the data show that the distribution of FVa and FXa at the site of vascular injury is to a large extent on the damaged endothelium with minor contributions from platelets. Further, a significant reduction of adherent platelets at the core injury site had little impact on the total amount of prothrombinase or fibrin detected. These results challenge long-standing models of blood coagulation in which activated platelets are the primary site for prothrombinase assembly.
Thus while activated platelets can support robust thrombin generation in vitro, this role in vivo may be much more limited than previously appreciated. Animals. Hemophilia B (HB) mice on the Balb/c strain have been previously described and backcrossed for more than 5 generations. 24, 25 Wild-type (wt)-Balb/c mice were purchased from Jackson Laboratory (Bar Harbor, ME). Tie2-GFP mice on the FVB/N background were obtained from Jackson Laboratory (Bar Harbor, ME). These mice express green fluorescent protein (GFP) under the control of the endothelial specific receptor tyrosine kinase (Tie2)
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promoter. 26 To obtain HB-Tie2-GFP mice, Tie2-GFP mice were crossed with HB mice (Balb/c) and bred for more than 5 generations. For all experiments, mice were between 8-12 weeks of age and weighed 25 to 30 g. Experimental approval was obtained from the Children's Hospital of Philadelphia Institutional Animal Care and Use Committee.
Real-time in vivo imaging of thrombus formation: Evaluation of hemostasis following laser injury to the cremaster muscle has been previously described and our specific experimental system has been detailed. 12, 27, 28 For personal use only. on April 12, 2017 . by guest www.bloodjournal.org From hemophilic mice that could be corrected by pre-infusion of human FVa to levels comparable to those seen following reconstitution with either FVIII or FIX. 27 It therefore follows that some or all of the infused FVa localized at the site of the growing hemostatic plug must be functional and complexed with endogenous FXa to generate thrombin. These observations form the basis for our experimental design to employ HB mice as a platform to image the constituents of prothrombinase in the developing clot. This approach was chosen to minimize the confounding possibility that a significant fraction of FVa or FXa localized at the site of injury may be nonproductively or adventitiously bound in a way that is irrelevant to thrombin formation.
To examine whether this model resembles hemostatic plug formation in wt-animals, we For
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This suggestion was further pursued using labeled annexin V to reveal phosphatidylserine exposure following laser injury. 23 , 5B and Supplemental Video 5A). Prior treatment with integrilin greatly reduced platelets at the core injury site but without altering the kinetics and distribution of Alexa 488 -FV-810 SYA and Alexa 647 -FXa i while the total amount of these proteins was reduced about 50% (Fig. 5A , 5B and Supplemental Video 5B). These conclusions were further supported by 3D reconstructions from thrombi at approximately 3 min show that while platelets at the injury site were substantially reduced, the constituents of prothrombinase were not (Fig. 6A) .
The pharmacologic or genetic reduction of platelets also had essentially no impact on fibrin deposition (Fig. 6 ). This was evident following analysis of total fibrin 3 min post injury in both integrilin treated HB mice or in Par4 -/-mice (± integrilin; Fig. 6A ). In addition to total fibrin, the kinetics of fibrin accumulation was also unchanged (Fig. 6B ). Two and three dimensional image analysis shows that the fibrin is only partly associated with platelets and FVa and appears more distal to these components in either the absence or presence of integrilin ( For personal use only. on April 12, 2017 . by guest www.bloodjournal.org From
DISCUSSION
Current ideas defining the cellular control of the hemostatic response to vascular damage center on the adherent and activated platelet as the primary biologic surface for the assembly and function of the prothrombinase and intrinsic Xase complexes of coagulation. 37 This view is rooted in the ability of isolated platelets to support the assembly and function of prothrombinase and intrinsic Xase following activation with physiologically relevant agonists, the intimate association of activated platelets with fibrin within the thrombus and the established observation of bleeding in humans with thrombocytopenia or platelet disorders. 38 However, given the key structural contributions of fibrin and aggregated/adherent platelets to thrombus stability, it does not necessarily or logically follow that bleeding seen upon a reduction in platelet function/levels reflects their primary contribution to prothrombinase assembly, thrombin formation and resulting fibrin deposition. The conjecture that the activated platelet is the primary biologic surface for thrombin formation needs further tempering by the unknown agonist concentration profiles during the response to vascular damage in flowing blood. 34 Thus, while platelets may readily be activated by "optimal" concentrations of agonists to support coagulation enzyme complex function under contrived conditions in vitro, their extent of activation within and around the evolving thrombus may be insufficient to allow their implied primary and robust contribution to prothrombinase or intrinsic Xase function.
In this study, we circumvent these limitations by examining the distribution of prothrombinase in the area of vascular damage following laser injury to the cremaster arteriole in the living mouse.
While prothrombinase may be present on a limited subset of platelets present at the core of the thrombus, the striking observation is that both FXa and FVa are much more broadly distributed on the vessel wall in the area surrounding the injury site but lacking adherent platelets. We surmise that this extended distribution reflects their binding to activated or damaged endothelial cells found in the vicinity of vascular damage. It is also possible that there are contributions from microparticles and neutrophils as these membranous surfaces have been proposed to contribute to thrombus formation. 9, 39 Such activated surfaces, other than those provided by adherent platelets, must support thrombin formation in a robust way as genetic or pharmacologic manipulations to yield large reductions in platelets adherent to the injury site produced modest effects on the distribution of the bound constituents of prothrombinase and only minimal decreases in fibrin deposition. This synopsis outlines our observations that question the preeminent role ascribed to the surface of the activated platelet in supporting the assembly and function of prothrombinase in vivo.
At issue is whether surfaces that play an especially important role in supporting functional prothrombinase assembly and thrombin formation are somehow obscured for reasons of sensitivity. This would require that the specific activity of bound prothrombinase is highly dependent on cell type or just not governed by physical principles as established in purified systems with synthetic membranes. 40, 41 While there is no sound evidence to support either possibility, we are unable to address this question directly. Instead, we have used a variety of alternative strategies to deplete the bulk of adherent platelets to partially address this concern.
Nevertheless, it remains possible that a small subset of activated platelets present at the core of the thrombus support the binding of FXa and FVa in a way that is essential for the hemostatic response. It is for this reason that we phrase our conclusions in terms of the broad distribution of bound FXa and FVa both at the core of the injury site where platelets are present as well as more
For personal use only. on April 12, 2017. by guest www.bloodjournal.org From extended regions where adherent platelets are not detected. Thereby suggesting a far more substantial role than previously anticipated for other activated cells highlighted by the activated endothelium rather than just platelets in supporting the assembly and function of prothrombinase.
The recent documentation that more extensively activated platelets are found in a limited core region of the thrombus adjacent to the vessel wall and the localization of annexin V binding to this limited region warrant this type of circumspect conclusion. 34, 42 Our findings question the functional demarcation of procoagulant function attributed to platelets (and possibly other blood cells such as neutrophils and microparticles) and the anticoagulant role played by the endothelium in selectively supporting the activation of protein C. 43 While venous endothelial cells in culture have long been known to support prothrombinase assembly and thrombin formation, the biologic significance of these observations has been uncertain. 44 culture. 15 The latter principle is surprising given the accepted propensity of platelets to activation. 45 It is nevertheless consistent with the finding that only a limited number of platelets at the core of the thrombus actually express P-selectin on their surface. 34 The significance of laser-induced damage in the mouse cremaster arteriole to the different forms of vascular injury relevant to normal or pathological thrombus formation in humans is arguable.
However, close parallels between the response to laser damage and a microscopic piercing injury to the blood vessel done with a micropipette, implicates the laser injury model as most relevant to hemostasis rather than pathological thrombus formation. 34 The latter by its nature is more complicated and typically involves several abnormalities. The laser injury model and our findings may not accurately portray the relative contributions of the activated endothelium versus platelets to coagulation enzyme complex assembly under pathological conditions such as plaque rupture or disseminated intravascular coagulation. Our conclusions also need modulation in terms of the specific injury model that we have used with qualifiers that the outcome may be dependent on vessel size, in the venous versus arterial system and type of injury. [46] [47] [48] Differences with the cremaster laser injury model in different injury scenarios could also yield alternative outcomes in terms of prothrombinase distribution and contribution of platelets to thrombin generation. Interestingly however, Cooley and colleagues have established parallels between some of our observations and the response to electrolytic injury in large veins. Pharmacologic inhibition of platelet adhesion had only a minor effect on fibrin levels at the injury site again highlighting the importance of cells other than platelets contributing to thrombin generation. 49, 50 The finding that such effects were not as striking in electrolytic injury to large arteries further justifies carefully qualified interpretation of our findings. Relating the outcome in the different mouse models to human physiology and pathology remains a future challenge to the field. In contrast to the widely accepted idea that the activated platelet is the primary biologic surface for the assembly and function of the prothrombinase, we now show a prominent contribution for the activated endothelium adjacent to the site of damage in these processes. While we have not presently studied the distribution of the components of intrinsic Xase, it seems possible that similar conclusions may apply for FIXa and FVIIIa as well. The contribution of different cell types to the function of clotting factor complexes likely adds an underappreciated dimension of control to thrombus formation or limiting thrombus formation in vivo by partitioning reactants and products to different surfaces. 
